osimertinib
astrazeneca
['adaura', '$azn']
interesting criticism of adaura, getting some traction now $azn #asco23 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.